Canonical: https://ownershiptrace.com/13f/companies/4353

# Who owns Arcutis Biotherapeutics, Inc. (ARQT)? Elite investor 13F holders

4 tracked elite investors reported holding Arcutis Biotherapeutics, Inc as of 2026-06-30, including Rubric Capital, D.E. Shaw, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Rubric Capital](https://ownershiptrace.com/13f/investors/120) | ARCUTIS BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 216880749.00 USD | 8271577.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1687509/0001104659-26-097098-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ARCUTIS BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 103558748.00 USD | 3949609.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ARCUTIS BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1531222.00 USD | 58399.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ARCUTIS BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 499019.00 USD | 19032.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)